The Keenan Blog

Blog

IVF Coverage Under SB 729: Key Considerations for Employers

California’s health benefits landscape continues to evolve. With SB 729, the state has introduced a new requirement for infertility treatment coverage, including in vitro fertilization (IVF), for certain health plans. For employers, this change raises important questions about cost, plan design, and long-term strategy.

What SB 729 requires

SB 729 expands access to infertility treatment by requiring certain fully insured large group health plans to cover infertility services, including IVF, beginning in 2026.

While regulatory guidance continues to develop, the intent is clear: broaden access to care that has historically been limited or excluded.

For context on related legislative activity and timing changes, read California Legislature Introduces Health Omnibus Bill.

Understanding the budget impact

Adding IVF coverage introduces a new cost driver for employer-sponsored health plans. The extent of the impact will vary based on plan structure, population, and utilization patterns.

Key considerations include:

• Increased claims exposure – IVF is a high-cost service. Even limited utilization can result in measurable increases in overall plan spend.
• Utilization uncertainty – Employers may not have historical data for IVF usage within their population. This creates challenges in forecasting and budgeting.
• Premium adjustments for fully insured plans – Carriers are expected to incorporate the mandate into pricing, which may result in higher renewal rates for affected plans.
• Long-term cost considerations – While IVF increases upfront costs, some studies suggest it may reduce downstream costs related to high-risk pregnancies when managed appropriately. Employers should take a balanced, long-term view.

Strategic considerations for employers

SB 729 is not just a compliance requirement. It is an opportunity to revisit pharmacy and medical plan strategy, vendor alignment, and overall cost management.

• Evaluate plan design options – Employers should work with their advisors to understand how the mandate applies to their specific plan and explore available options. This may include reviewing coverage limits, cost-sharing structures, and integration with existing benefits.
• Coordinate with pharmacy strategy – Fertility treatment often involves specialty medications. Aligning IVF coverage with a strong pharmacy strategy can help manage costs and improve outcomes.
• Assess population and workforce needs – Understanding employee demographics can help employers anticipate utilization and tailor communication and support resources effectively.
• Strengthen budget planning and forecasting – Given the variability associated with IVF utilization, scenario planning is essential. Employers may consider modeling best- and worst-case scenarios to inform budgeting decisions.

Communication and employee support

As with any benefit change, communication plays a critical role. IVF coverage can be complex, and employees will need clear, accessible information.

Best practices include:

• Providing simple explanations of what is covered
• Clarifying eligibility and any limitations
• Offering guidance on how to access care and support services

A clear, informed approach helps employees make thoughtful decisions while supporting plan sustainability.

Positioning SB 729 within a broader strategy

SB 729 introduces a meaningful shift in required health plan coverage. While it may increase near-term costs, it also provides an opportunity to strengthen benefits strategy and improve access to care.

With thoughtful planning and clear communication, employers can meet compliance requirements while maintaining control over costs and supporting their employees’ needs. Keenan’s role is to support clients with practical, data-informed guidance that helps navigate these changes with confidence.